Core Viewpoint - Rosen Law Firm is reminding purchasers of Lineage, Inc. common stock about the September 30, 2025 lead plaintiff deadline for a class action lawsuit related to the company's July 2024 IPO [1] Group 1: Class Action Details - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 30, 2025 [3] - The lawsuit claims that the registration statement was false and/or misleading, failing to disclose significant issues affecting Lineage's business operations and financial results [5] Group 2: Reasons for Legal Action - The lawsuit alleges that Lineage experienced a decline in customer demand due to increased cold-storage supply and destocking of excessive inventory by customers [5] - It is claimed that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [5] - The company reportedly could not counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or falling revenue and occupancy rates [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been recognized for its performance in securities class action settlements [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fly-E Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on November 10, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Fly-E securities between July 15, 2025, and August 14, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the November 10, 2025 deadline [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in terms of settlements since 2013 [3]. Group 3: Case Background - The lawsuit alleges that Fly-E Group provided misleading statements regarding the safety of its lithium battery, which negatively impacted its E-vehicle sales revenue, despite optimistic long-term projections [4]. - The decline in sales and increase in operating expenses ultimately led to a failure in meeting revenue projections, resulting in investor damages when the true situation was revealed [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the October 10, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased SelectQuote securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by October 10, 2025, to serve as lead plaintiff [2] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons [4] - It is claimed that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers, which resulted in non-compliance with laws and regulations [4] - The lawsuit asserts that the misleading statements about SelectQuote's business led to investor damages when the true details became public [4]

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Snap Inc. (NYSE: SNAP) between April 29, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), both dates inclusive, of the important October 20, 2025 lead plaintiff deadline. SO WHAT: If you purchased Snap securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arran ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Cytokinetics, Inc. common stock during the specified Class Period, alleging misleading statements regarding the New Drug Application for aficamten [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to Cytokinetics, Inc. and covers stock purchases made between December 27, 2023, and May 6, 2025 [1]. - The lawsuit claims that Cytokinetics made false statements about the expected approval timeline for aficamten, specifically regarding the FDA's approval process and the failure to disclose risks related to the Risk Evaluation and Mitigation Strategy [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting Rosen Law Firm directly for more information [3][6]. - A lead plaintiff must be appointed by November 17, 2025, to represent the class in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of sellers of ordinary shares of Sina Corporation, specifically those who sold shares during the merger period from October 13, 2020, to March 22, 2021, alleging a fraudulent scheme to depress share value [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants misrepresented and omitted material information in Sina's proxy materials related to the merger, which misled shareholders [5]. - It is alleged that the true value of Sina's investment in TuSimple was concealed, leading to an undervaluation of the offer of $43.30 per ordinary share during the merger [5]. - The lawsuit asserts that when the true details became public, investors suffered damages due to the misleading statements about Sina's business and prospects [5]. Group 2: Participation Information - Sellers of Sina ordinary shares during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must file a motion with the court by November 18, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked in the top 4 for securities class action settlements since 2013 and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing shareholder interests [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Synopsys, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Company Performance - On September 9, 2025, Synopsys released its financial results for the third quarter of fiscal year 2025, where the CEO acknowledged that the IP business underperformed expectations [4]. - Following the earnings announcement, Synopsys shares fell by $216.59 per share, or 35.8%, closing at $387.78 on September 10, 2025, after missing both top and bottom-line consensus estimates [4]. Group 2: Legal Actions - Investors who purchased Synopsys securities may be entitled to compensation through a class action lawsuit being prepared by Rosen Law Firm, which operates on a contingency fee basis [2]. - The firm encourages investors to select qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Spectrum Pharmaceuticals, Inc. during the specified class period of the upcoming lead plaintiff deadline on September 24, 2025, as the lead plaintiff process has been reopened by the Court [1]. Group 1: Class Action Details - Investors who bought Spectrum Pharmaceuticals common stock between May 12, 2022, and September 22, 2022, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed against Spectrum Pharmaceuticals, and interested parties can join by contacting the law firm [3]. - The lawsuit alleges that Spectrum made false or misleading statements regarding its PINNACLE Study, which involved the drug poziotinib for lung cancer treatment, leading to investor damages when the truth was revealed [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms issuing notices may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a record settlement against a Chinese company and significant recoveries for investors in previous years [4]. Group 3: Class Certification Status - No class has been certified yet, meaning investors are not represented by counsel unless they choose to retain one [6]. - Investors can opt to remain absent class members and are not required to serve as lead plaintiffs to share in any potential future recovery [6].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of KBR, Inc. securities purchasers during the specified Class Period, alleging that the company made materially false and misleading statements regarding its business operations and prospects [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to KBR, Inc. securities purchased between May 6, 2025, and June 19, 2025 [1]. - The lawsuit claims that KBR's management misrepresented the status of its partnership with the U.S. Department of Defense's Transportation Command, despite known concerns about HomeSafe's ability to fulfill contractual obligations [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the KBR class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by November 18, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its leadership in securities class action settlements and has consistently ranked among the top firms in this area since 2013 [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of V.F. Corporation securities between October 30, 2023, and May 20, 2025, alleging that the company disseminated materially false and misleading statements regarding its turnaround plans [1][5]. Group 1: Lawsuit Details - The lawsuit claims that V.F. Corporation concealed significant reset actions necessary for the Vans brand to return to growth, which negatively impacted revenue growth [5]. - Investors who purchased V.F. Corporation securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by November 12, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking in the top 4 since 2013 [4].